Neuron Enrichment via Surface Marker Selection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for differentiating human pluripotent stem cells into neural cells result in heterogeneous populations, making it difficult to obtain pure neuron populations, which is a limitation for cell replacement therapies and research, as they contain mixed cell types and stages, reducing safety and efficacy and increasing the risk of side effects.
Innovation Solution
A method involving the selection and exclusion of cells based on specific surface markers such as PTPRO, ADGRG1, and CD47 to enrich for neurons and precursors, utilizing a process that includes culturing neural stem cells until SOX2 expression decreases, allowing for the identification and isolation of cells with a higher propensity for neuronal development.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If conventional differentiation protocols are used to generate neural cells, then the process is relatively simple and can be performed with standard methods, but the resulting cell population is heterogeneous and contains mixed cell types
Solution Approach 1:
The patent extracts and removes unwanted cell types from the heterogeneous neural cell population by using magnetic beads conjugated to antibodies against specific surface markers (such as CD99, CD47, CD83) that are expressed on non-neuronal cells. This extraction process selectively depletes glial cells and other unwanted cell types, leaving an enriched population of neurons and neuronal precursors, thereby improving cell population homogeneity while maintaining the simplicity of the overall differentiation process
Solution Approach 2:
The patent applies local quality by using flow cytometry to identify and sort cells based on their specific surface marker expression patterns. By analyzing individual cell properties (such as CD99, CD47, CD83 expression) and sorting based on these local characteristics, the method achieves homogeneous cell populations without requiring complex global changes to the differentiation protocol
2Reliability
If heterogeneous cell populations are used for cell replacement therapy, then the therapy can be performed with current technology, but the safety and efficacy are reduced and side effects increase
Solution Approach 1:
The patent applies preliminary action by performing magnetic bead-based depletion of unwanted cell types and flow cytometry-based sorting before the cell therapy is administered to patients. This preliminary purification step ensures that only homogeneous neuronal cells are used for therapy, improving safety and efficacy while avoiding the need for complex post-therapy interventions to manage heterogeneous cell populations
Solution Approach 2:
The patent uses flow cytometry as a feedback mechanism to monitor and verify the purity of the neuronal cell population at multiple stages of the differentiation process. By continuously analyzing surface marker expression (CD99, CD47, CD83) and adjusting the sorting parameters accordingly, the method ensures high cell population homogeneity and reliability for therapeutic applications
Data Source
AI summary
The present invention relates to a method for providing a cell population enriched in neurons and/or precursors thereof, comprising the steps of obtaining a cell population comprising neuron precursors, and selecting cells positive indicative of whether a cell has high propensity for developing into a neuron.